Pulmonary vein stenosis: prematurity and associated conditions.
(33/87)
(+info)
Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives.
(34/87)
(+info)
Pulmonary veno-occlusive disease.
(35/87)
(+info)
Pulmonary veno-occlusive disease in myeloproliferative disorder.
(36/87)
(+info)
Complications in the catheter ablation of atrial fibrillation: incidence and management.
(37/87)
Radiofrequency catheter ablation is widely performed as an effective treatment for recurrent, drug-resistant atrial fibrillation (AF). Recently, various types of ablation strategies, such as extensive encircling pulmonary vein (PV) isolation, linear ablation and complex fractionated electrogram-guided ablation, have been used to achieve a high efficacy for all types of AF. However, several complications (thromboembolic events, PV stenosis and atrio-esophageal fistula etc) with an incidence of 3.9-6%, have been reported. It is important to understand the incidence, prevention and management of complications in order to develop safe ablation strategies. (+info)
Development of novel drug-eluting biodegradable nano-fiber for prevention of postoperative pulmonary venous obstruction.
(38/87)
(+info)
Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture.
(39/87)
(+info)
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy.
(40/87)
(+info)